tiprankstipranks
Advertisement

PABD - ETF AI Analysis

Compare

Top Page

PABD

iShares Paris-Aligned Climate MSCI World ex USA ETF (PABD)

Rating:65Neutral
Price Target:
PABD, the iShares Paris-Aligned Climate MSCI World ex USA ETF, has a solid overall rating, suggesting it holds generally strong, well-established companies outside the U.S. Top holdings like Novartis, HSBC, AstraZeneca, and ABB support the fund’s quality through strong financial performance, positive earnings sentiment, and reasonable valuations, especially in healthcare and financials. The main risk is that several key holdings show signs of being expensive or near overbought levels, which could limit future gains and add volatility even though the underlying businesses are strong.
Positive Factors
Strong Leading Holding
ASML, the fund’s largest position, has shown strong performance this year, helping support overall returns.
Broad Global Diversification
The ETF spreads its investments across many countries outside the U.S., which helps reduce the impact of problems in any single market.
Low Expense Ratio
The fund charges relatively low fees, so more of the investment gains can stay in investors’ pockets over time.
Negative Factors
Mixed Performance Among Top Holdings
While several major positions have performed well, at least one key holding has been weak, which can drag on the fund’s results.
Heavy Exposure to Financials
A large share of the portfolio is invested in financial companies, which can make the fund more sensitive to banking and interest-rate risks.
Recent Short-Term Weakness
The ETF has shown slightly negative performance over the past month, suggesting some near-term volatility despite its positive year-to-date trend.

PABD vs. SPDR S&P 500 ETF (SPY)

PABD Summary

PABD is an ETF that follows the MSCI World ex USA Climate Paris Aligned Index, focusing on companies outside the U.S. that are working to cut carbon emissions and support global climate goals. It holds a wide mix of international stocks from places like Japan, the UK, and Canada, including well-known names such as ASML Holding and Royal Bank of Canada. Investors might consider PABD for global diversification while supporting environmentally conscious businesses. A key risk is that the fund still moves up and down with global stock markets, and it is especially exposed to financial and industrial companies.
How much will it cost me?The iShares Paris-Aligned Climate MSCI World ex USA ETF (PABD) has an expense ratio of 0.12%, meaning you’ll pay $1.20 per year for every $1,000 invested. This is lower than average because it’s passively managed, tracking an index rather than relying on active stock-picking strategies.
What would affect this ETF?Positive drivers for PABD include the growing global focus on sustainability and climate action, which could benefit companies aligned with the Paris Agreement goals. However, economic slowdowns in developed markets outside the U.S. or regulatory changes affecting key sectors like financials and technology could negatively impact the ETF's performance.

PABD Top 10 Holdings

PABD’s story is driven by a mix of climate-conscious heavyweights outside the U.S., with a clear tilt toward financials and industrials in developed markets like Europe, Canada, and Japan. Banks such as Royal Bank of Canada, HSBC, Mitsubishi UFJ, and TD are all rising and doing much of the heavy lifting for the fund. ASML and ABB add a tech-and-industrial green transition angle, also trending positively over the longer run. On the flip side, AstraZeneca and Schneider Electric have been losing a bit of steam lately, modestly dragging on recent performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.04%$10.29M€572.60B143.26%
76
Outperform
Royal Bank Of Canada1.56%$5.28M$293.84B57.98%
75
Outperform
Novartis AG1.49%$5.06MCHF230.61B32.06%
80
Outperform
Roche Holding AG1.43%$4.84M$361.51B51.16%
73
Outperform
HSBC Holdings1.43%$4.83M£262.77B60.76%
80
Outperform
Schneider Electric1.32%$4.47M€171.50B39.00%
62
Neutral
ABB Ltd1.18%$3.99Mkr1.72T55.38%
78
Outperform
AstraZeneca1.12%$3.79M$249.26B8.64%
80
Outperform
Toronto Dominion Bank1.08%$3.67M$205.29B65.68%
74
Outperform
Mitsubishi UFJ Financial Group1.06%$3.60M¥39.85T52.16%
76
Outperform

PABD Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
69.17
Positive
100DMA
67.62
Positive
200DMA
65.92
Positive
Market Momentum
MACD
0.79
Negative
RSI
63.48
Neutral
STOCH
86.03
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PABD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 69.96, equal to the 50-day MA of 69.17, and equal to the 200-day MA of 65.92, indicating a bullish trend. The MACD of 0.79 indicates Negative momentum. The RSI at 63.48 is Neutral, neither overbought nor oversold. The STOCH value of 86.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PABD.

PABD Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$340.79M0.12%
65
Neutral
$290.92M0.22%
65
Neutral
$217.60M0.68%
59
Neutral
$166.27M0.68%
66
Neutral
$83.07M0.48%
60
Neutral
$82.64M0.12%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PABD
iShares Paris-Aligned Climate MSCI World ex USA ETF
71.60
11.69
19.51%
LCTD
BlackRock World ex U.S. Carbon Transition Readiness ETF
SNSR
Global X Internet of Things ETF
FINX
Global X Fintech Etf
IFGL
iShares International Developed Real Estate ETF
FEDM
FlexShares ESG & Climate Developed Markets ex-US Core Index Fund ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement